Inhibition of esophageal cancer growth through the suppression of PI3K/AKT/mTOR signaling pathway
Ni Shi,* Hao Yu,* Tong Chen Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA*These authors contributed equally to this workCorrespondence: Tong ChenDivision of Medical Oncology, Department of Internal Medicine, The Ohio State University, 410...
Main Authors: | Shi N, Yu H, Chen T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-09-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/inhibition-of-esophageal-cancer-growth-through-the-suppression-of-pi3k-peer-reviewed-article-OTT |
Similar Items
-
Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis
by: Zou H, et al.
Published: (2016-05-01) -
Developing a novel dual PI3K–mTOR inhibitor from the prodrug of a metabolite
by: Zhou Y, et al.
Published: (2017-10-01) -
Ciblage de la voie PI3K/mTOR dans les léiomyosarcomes : sensibilité et mécanismes de résistance
by: Fourneaux, Benjamin
Published: (2017) -
Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells
by: Hyera Kim, et al.
Published: (2020-04-01) -
High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors
by: Daniel J. Smit, et al.
Published: (2020-09-01)